Complicaciones neurológicas de la COVID-19, breve revisión de la literatura
DOI:
https://doi.org/10.66737/ier.zub.284Keywords:
COVID-19, neurologic complications, SARS-CoV-2Abstract
COVID-19, caused by the virus SARS-CoV-2, is a multiorgan disease with a wide spectrum of clinical manifestations, including neurological symptoms with mild or severe presentation, which are expressed in all stages of the disease, from acute disease to those who develop long-term symptoms, what has been called post-COVID syndrome. Common neurological symptoms include headache, smell and taste disorders, and nonspecific symptoms, such as fatigue, myalgia or cognitive impairment, some of them with a chronic presentation. To these symptoms, in patients with severe illness and hospitalized, could be added encephalopathy
and dizziness, and less frequently but more seriously, cerebrovascular or neuromuscular diseases, as Guillain Barré syndrome. Here, we provide a brief review about the neurologic complications in patients with COVID-19.
Downloads
References
Al-Ramadan, A., Rabab’h, O., Shah, J., & Gharaibeh, A. (2021). Acute and post-acute neurological complications of COVID-19. Neurology International, 13(1), 102-119.
CDC, 2020. El COVID-19 y su salud [WWW Document]. Centers for Disease Control and Prevention. URL: https://espanol.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (accessed 4.2.21).
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., ... & Solomon, T. (2020). Neurological associations of COVID-19. The Lancet Neurology, 19(9), 767-783.
Fragiel, M., Miró, Ò., Llorens, P., Jiménez, S., Piñera, P., Burillo, G., ... & SIESTA (Spanish Investigators in Emergency Situations Team) network. (2021). Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Annals of neurology, 89(3), 598-603.
García-Azorín, D., Martínez-Pías, E., Trigo, J., Hernández-Pérez, I., Valle-Peñacoba, G., Talavera, B., ... & Arenillas, J. F. (2020). Neurological comorbidity is a predictor of death in Covid-19 disease: a cohort study on 576 patients. Frontiers in neurology, 781.
Gómez-Iglesias, P., Porta-Etessam, J., Montalvo, T., Valls-Carbó, A., Gajate, V., Matías-Guiu, J. A., ... & Matías-Guiu, J. (2020). An online observational study of patients with olfactory and gustory alterations secondary to SARS-CoV-2 infection. Frontiers in public health, 8, 243.
Graham, E. L., Clark, J. R., Orban, Z. S., Lim, P. H., Szymanski, A. L., Taylor, C., ... & Koralnik, I. J. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Annals of clinical and translational neurology, 8(5), 1073-1085.
Katsanos, A. H., Palaiodimou, L., Zand, R., Yaghi, S., Kamel, H., Navi, B. B., ... & Tsivgoulis, G. (2021). The impact of SARS-CoV-2 on stroke epidemiology and care: a meta-analysis. Annals of neurology, 89(2), 380-388.
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., ... & Lunn, M. P. (2021). Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain, 144(2), 682-693.
Kennedy, M., Helfand, B. K., Gou, R. Y., Gartaganis, S. L., Webb, M., Moccia, J. M., ... & Inouye, S. K. (2020). Delirium in older patients with COVID-19 presenting to the emergency department. JAMA network open, 3(11), e2029540-e2029540.
Liotta, E. M., Batra, A., Clark, J. R., Shlobin, N. A., Hoffman, S. C., Orban, Z. S., & Koralnik, I. J. (2020). Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Annals of clinical and translational neurology, 7(11), 2221-2230.
Miners, S., Kehoe, P. G., & Love, S. (2020). Cognitive impact of COVID-19: looking beyond the short term. Alzheimer’s research & therapy, 12(1), 1-16.
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., ... & Wan, E. Y. (2021). Post-acute COVID-19 syndrome. Nature medicine, 27(4), 601-615.
Pezzini, A., & Padovani, A. (2020). Lifting the mask on neurological manifestations of COVID-19. Nature Reviews Neurology, 16(11), 636-644.
Porta-Etessam, J., Matías-Guiu, J. A., González-García, N., Gómez Iglesias, P., Santos-Bueso, E., Arriola-Villalobos, P., ... & Matías-Guiu, J. (2020). Spectrum of headaches associated with SARS-CoV-2 infection: Study of healthcare professionals. Headache: The Journal of Head and Face Pain, 60(8), 1697-1704.
Porta-Etessam, J., Núñez-Gil, I. J., González García, N., Fernandez-Perez, C., Viana-Llamas, M. C., Eid, C. M., ... & Estrada, V. (2021). COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection, 49(4), 677-684.
Romero-Sánchez, C. M., Díaz-Maroto, I., Fernández-Díaz, E., Sánchez-Larsen, Á., Layos-Romero, A., García-García, J., ... & Segura, T. (2020). Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology, 95(8), e1060-e1070.
Stokes, E. K., Zambrano, L. D., Anderson, K. N., Marder, E. P., Raz, K. M., Felix, S. E. B., ... & Fullerton, K. E. (2020). Coronavirus disease 2019 case surveillance—United States, january 22–may 30, 2020. Morbidity and Mortality Weekly Report, 69(24), 759.
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry, 8(5), 416-427.
Thakur, K. T., Miller, E. H., Glendinning, M. D., Al-Dalahmah, O., Banu, M. A., Boehme, A. K., ... & Canoll, P. (2021). COVID-19 neuropathology at columbia university irving medical center/New York presbyterian hospital. Brain, 144(9), 2696-2708.
Trigo, J., García-Azorín, D., Planchuelo-Gómez, Á., Martínez-Pías, E., Talavera, B., Hernández-Pérez, I., ... & Guerrero, Á. L. (2020). Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. The journal of headache and pain, 21(1), 1-10.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 María Eugenia Marzo-Sola, Federico Castillo-Álvarez (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en Zubía conservan los derechos de autor de sus trabajos y autorizan a la revista la primera publicación de los mismos.
Los artículos se publican bajo la licencia Creative Commons Atribución–No Comercial–Compartir Igual (CC BY-NC-SA), que permite su uso, distribución y reproducción en cualquier medio, siempre que se cite adecuadamente la autoría original, no se realice un uso comercial y se mantenga la misma licencia.
